Hos patienter med seglcellesygdom blev hydroxycarbamid elimineret med en halveringstid på cirka 6 - 7 timer, hvilket er længere, end det, der er indberettet for andre indikationer.
In patients with Sickle Cell Syndrome hydroxycarbamide was eliminated with a half-life of approximately six to seven hours, which is longer than reported in other indications.